Time course of potentiation of mivacurium by halothane and isoflurane in children

British Journal of Anaesthesia

Volumn 76, Issue 2, 1996, Pages 235-238

  Meretoja, O A ^a   Wirtavuori, K ^a   Taivainen, T ^a   Olkkola, K T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Anaesthetics volatile, halothane; Anaesthetics volatile, isoflurane; Neuromuscular block, mivacurium; Pharmacodynamics

Indexed keywords

ALFENTANIL; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; THIOPENTAL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG POTENTIATION; HUMAN; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEUROMUSCULAR BLOCKING; PEDIATRIC SURGERY; PRIORITY JOURNAL; TIME;

EID: 0030043433     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/76.2.235     Document Type: Article

References (22)

1. Miller RD, Eger EI II, Way WL, Stevens WC, Dolan WM. Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man. Anesthesiology 1971; 35: 38-42.
2. Rupp SM, Miller RD, Gencarelli PJ. Vecuronium-induced neuromuscular blockade during enflurane, isoflurane, and halothane anesthesia in humans. Anesthesiology 1984; 60: 102-105.
3. Rupp SM, McChristian JW, Miller RD. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans. Anesthesiology 1985; 63: 16-19.
4. Swen J, Gencarelli PJ, Koot HWJ. Vecuronium infusion dose requirements during fentanyl and halothane anesthesia in humans. Anesthesia and Analgesia 1985; 64: 411-414.
5. Cannon JE, Fahey MR, Castagnoli KP, Furuta T, Canfell PC, Sharma M, Miller RD. Continuous infusion of vecuronium: the effect of anesthetic agents. Anesthesiology 1987; 67: 503-506.
6. From RP, Pearson KS, Choi WW, Abou-Donia M, Sokoll MD. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia. British Journal of Anaesthesia 1990; 64: 193-198.
7. Miller RD, Crique M, Eger EI II. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine. Anesthesiology 1976; 44: 206-210.
8. Stanski DR, Ham J, Miller RD, Sheiner LB. Time-dependent increase in sensitivity to d-tubocurarine during enflurane anesthesia in man. Anesthesiology 1980; 52: 483-487.
9. Withington DE, Donati F, Bevan DR, Varin F. Potentiation of atracurium neuromuscular blockade by enflurane: time-course of effect. Anesthesia and Analgesia 1991; 72: 469-473.
10. Weber S, Brandom BW, Powers DM, Sarner JB, Woelfel SK, Cook DR, Foster VJ, McNulty BF, Weakly JN. Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients. Anesthesia and Analgesia 1988; 67: 495-499.
11. Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn MC, Cook DR, McNulty BF, Foster VJ. Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesthesia and Analgesia 1989; 68: 116-121.
12. Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese JJ. Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology 1989; 70: 237-242.
13. Kalli I. Effect of surface electrode positioning on the compound action potential evoked by ulnar nerve stimulation in anaesthetized infants and children. British Journal of Anaesthesia 1989; 62: 188-193.
14. Meretoja OA, Olkkola KT. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion. British Journal of Anaesthesia 1993; 71: 232-237.
15. Gregory GA, Eger EI II, Munson ES. The relationship between age and halothane requirements in man. Anesthesiology 1969; 30: 488-491.
16. Cameron CB, Robinson S, Gregory GA. The minimum anesthetic concentration of isoflurane in children. Anesthesia and Analgesia 1984; 63: 418-420.
17. Alifimoff JK, Goudsouzian NG. Continuous infusion of mivacurium in children. British Journal of Anaesthesia 1989; 63: 520-524.
18. Brandom BW, Sarner JB, Woelfel SK, Dong ML, Horn MC, Borland LM, Cook DR, Foster VJ, McNulty BF, Weakly JN. Mivacurium infusion requirement in paediatric surgical patients during nitrous oxide-halothane and during nitrous oxide-narcotic anesthesia. Anesthesia and Analgesia 1990; 71: 16-22
19. Choi WW, Mehta MP, Murray DJ, Sokoll MD, Forbes RB, Gergis SD, Abou-Donia M, Kirchner J. Neuromuscular and cardiovascular effects of mivacurium chloride in surgical patients receiving nitrous oxide-narcotic or nitrous oxide-isoflurane anaesthesia. Canadian Journal of Anaesthesia 1989; 36: 641-650.
20. Powers DM, Brandom BW, Cook DR, Byers R, Sarner JB, Simpson K, Weber S, Woelfel SK, Foster VJ. Mivacurium infusion during nitrous oxide-isoflurane anesthesia: A comparison with nitrous oxide-opioid anesthesia. Journal of Clinical Anesthesia 1992; 4: 123-126.
21. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesthesia and Intensive Care 1990; 18: 440-448.
22. Meretoja OA, Taivainen T. Recent developments in muscle relaxation in children. Current Anaesthesia and Critical Care 1994; 5: 202-208.